508 related articles for article (PubMed ID: 34793745)
1. Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
Sabatine MS; Bergmark BA; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Christiansen EH; Holm NR; Nielsen PH; Stone GW; Sabik JF; Braunwald E
Lancet; 2021 Dec; 398(10318):2247-2257. PubMed ID: 34793745
[TBL] [Abstract][Full Text] [Related]
2. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
Holm NR; Mäkikallio T; Lindsay MM; Spence MS; Erglis A; Menown IBA; Trovik T; Kellerth T; Kalinauskas G; Mogensen LJH; Nielsen PH; Niemelä M; Lassen JF; Oldroyd K; Berg G; Stradins P; Walsh SJ; Graham ANJ; Endresen PC; Fröbert O; Trivedi U; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
Lancet; 2020 Jan; 395(10219):191-199. PubMed ID: 31879028
[TBL] [Abstract][Full Text] [Related]
4. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Coronary Intervention vs Coronary Artery Bypass Graft Surgery for Left Main Disease in Patients With and Without Acute Coronary Syndromes: A Pooled Analysis of 4 Randomized Clinical Trials.
Gaba P; Christiansen EH; Nielsen PH; Murphy SA; O'Gara PT; Smith PK; Serruys PW; Kappetein AP; Park SJ; Park DW; Stone GW; Sabik JF; Sabatine MS; Holm NR; Bergmark BA
JAMA Cardiol; 2023 Jul; 8(7):631-639. PubMed ID: 37256598
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
[TBL] [Abstract][Full Text] [Related]
8. Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.
Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
Lancet; 2018 Mar; 391(10124):939-948. PubMed ID: 29478841
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
Mäkikallio T; Holm NR; Lindsay M; Spence MS; Erglis A; Menown IB; Trovik T; Eskola M; Romppanen H; Kellerth T; Ravkilde J; Jensen LO; Kalinauskas G; Linder RB; Pentikainen M; Hervold A; Banning A; Zaman A; Cotton J; Eriksen E; Margus S; Sørensen HT; Nielsen PH; Niemelä M; Kervinen K; Lassen JF; Maeng M; Oldroyd K; Berg G; Walsh SJ; Hanratty CG; Kumsars I; Stradins P; Steigen TK; Fröbert O; Graham AN; Endresen PC; Corbascio M; Kajander O; Trivedi U; Hartikainen J; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
Lancet; 2016 Dec; 388(10061):2743-2752. PubMed ID: 27810312
[TBL] [Abstract][Full Text] [Related]
10. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
[TBL] [Abstract][Full Text] [Related]
11. Drug-Eluting Stents Versus Coronary Artery Bypass Grafts for Left Main Coronary Disease: A Meta-Analysis and Review of Randomised Controlled Trials.
Moore P; Burrage M; Garrahy P; Lim R; McCann A; Camuglia A
Heart Lung Circ; 2018 Dec; 27(12):1437-1445. PubMed ID: 29102437
[TBL] [Abstract][Full Text] [Related]
12. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.
Stone GW; Sabik JF; Serruys PW; Simonton CA; Généreux P; Puskas J; Kandzari DE; Morice MC; Lembo N; Brown WM; Taggart DP; Banning A; Merkely B; Horkay F; Boonstra PW; van Boven AJ; Ungi I; Bogáts G; Mansour S; Noiseux N; Sabaté M; Pomar J; Hickey M; Gershlick A; Buszman P; Bochenek A; Schampaert E; Pagé P; Dressler O; Kosmidou I; Mehran R; Pocock SJ; Kappetein AP;
N Engl J Med; 2016 Dec; 375(23):2223-2235. PubMed ID: 27797291
[TBL] [Abstract][Full Text] [Related]
13. Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
Park DW; Ahn JM; Park H; Yun SC; Kang DY; Lee PH; Kim YH; Lim DS; Rha SW; Park GM; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ;
Circulation; 2020 May; 141(18):1437-1446. PubMed ID: 32223567
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial.
Thuijs DJFM; Kappetein AP; Serruys PW; Mohr FW; Morice MC; Mack MJ; Holmes DR; Curzen N; Davierwala P; Noack T; Milojevic M; Dawkins KD; da Costa BR; Jüni P; Head SJ;
Lancet; 2019 Oct; 394(10206):1325-1334. PubMed ID: 31488373
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
[TBL] [Abstract][Full Text] [Related]
16. Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation.
Takahashi K; Serruys PW; Fuster V; Farkouh ME; Spertus JA; Cohen DJ; Park SJ; Park DW; Ahn JM; Kappetein AP; Head SJ; Thuijs DJ; Onuma Y; Kent DM; Steyerberg EW; van Klaveren D;
Lancet; 2020 Oct; 396(10260):1399-1412. PubMed ID: 33038944
[TBL] [Abstract][Full Text] [Related]
17. Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease: A systematic review and meta-analysis.
Zhang J; Jiang T; Hou Y; Chen F; Yang K; Sang W; Wu H; Ma Y; Xu F; Chen Y
Atherosclerosis; 2020 Sep; 308():50-56. PubMed ID: 32713512
[TBL] [Abstract][Full Text] [Related]
18. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.
Mohr FW; Morice MC; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Morel MA; Van Dyck N; Houle VM; Dawkins KD; Serruys PW
Lancet; 2013 Feb; 381(9867):629-38. PubMed ID: 23439102
[TBL] [Abstract][Full Text] [Related]
19. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
20. Sex-Specific Outcomes Following Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Left Main Disease: A Systematic Review and Meta-Analysis.
Zhou JY; Tie EN; Liew D; Duffy SJ; Shaw J; Walton A; Chan W; Stub D
Heart Lung Circ; 2022 May; 31(5):658-665. PubMed ID: 35033432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
